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Reversal of renal cortical actions of angiotensin II by
verapamil and manganese
IEKUNI ICHIKAWA, JOSEPH F. MIELE, and BARRY M. BRENNER
Laboratory of Kidney and Electrolyte Physiology and Departments of Medicine, Peter Bent Brigham Hospital
and Harvard Medical School, Boston, Massachusetts
Reversal of renal cortical actions of angiotensin II by verapamil
and manganese. Experiments were performed on 19 euvolemic
Munich Wistar rats to examine the role of calcium in the action
of angiotensin II (All) on the glomerular microcirculation. Intra-
venous infusion of a mildly pressor dose of All (N = 7 rats) led to
a significant rise in mean glomerular capillary hydraulic pressure
(PGC) and significant declines in glomerular plasma flow rate (QA)
and the ultrafiltration coefficient (Kf). Because of these offsetting
effects, single nephron GFR (SNGFR) and total kidney GFR
failed to change significantly. Both afferent and efferent arteri-
olar resistances (RA and RE) increased during All infusion, on
average by approximately 40% and 75%, respectively. Despite
continued All infusion, addition of verapamil led to return of
values for P, QA, Kf, RA, and RE essentially to pre-AlI levels.
In 7 other rats, verapamil infusion alone failed to exert significant
influences on these indices. Likewise, no significant changes in
these measures were observed when this same dose of All was
infused into verapamil-pretreated animals. Moreover, intrarenal
arterial injection of a nonpressor dose of All into 6 other rats also
resulted in changes in P, QA' Kf, and RE similar to those seen
during intravenous infusion, and addition of manganese abol-
ished these effects. Since verapamil and manganese are
both known to interfere with excitation-contraction coupling of
smooth muscle, perhaps by inhibiting transcellular calcium
transport, the present results suggest that the calcium ion may be
an important cofactor required for the expression of All action
on the glomerular microcirculation, by affecting mesangial and
efferent arteriolar smooth muscle contractility.
Reversion par le vérapamil et le manganese des actions de
l'angiotensine U sur le cortex renal. Des experiences ont été real-
isées sur 19 rats Munich Wistar euvolémiques afin d'étudier le
role du calcium dans l'action de l'angiotensine II sur Ia micro-
circulation glomerulaire. La perfusion intraveineuse d'une dose
modérCment pressive d'AII (N = 7 rats) determine une augmen-
tation significative de Ia pression hydraulique capillaire gloméru-
laire moyenne (PGC) et des diminutions significatives du debit
plasmatique glomerulaire (QA) et du coefficient d'ultrafiltration
(Kf). Du fait de l'annulation réciproque de ces effets les debits de
filtration individuels (SNGFR) et globaux (GFR) ne changent pas
significativement. Les resistances artériolaires afférente et ef-
férente (RA et RE) augmentent au cours de Ia perfusion d'AII, en
moyenne de 40% et 75%, respectivement. Malgré Ia poursuite de
Ia perfusion d'AII l'administration de vérapamil determine un
retour aux valeurs initiales de GC, QA, Kf, RA, et RE. Chez 7
autres rats Ia perfusion de verapamil seul n'influence pas signifi-
cativement ces variables. II n'est pas observe non plus de modifi-
cation significative des ces variables quand Ia même dose d'AII
est administréc a des animaux pré-traités par le vérapamil. De
plus, l'injection dans l'artère rénale d'une dose non pressive
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d'AII chez 6 autres rats determine aussi des modifications de
PGC, QA, Kf, et RE semblables a celles observées au cours de
l'injection intraveineuse et l'addition de manganese abolit encore
ces effets. Du fait que le verapamil et Ic manganese sont tous
deux connus pour interferer avec le couplage excitation-con-
traction du muscle lisse, probablement par I'inhibition du trans-
port de calcium transcellulaire, les résultats suggèrent que l'ion
calcium peut étre un co-facteur important nécessaire a
l'expression de l'action de All sur Ia microcirculation glomeru-
laire en affectant Ia contractilité du muscle lisse mesangial et
artériolaire efférent.
The accessibility of surface glomeruli in the Mu-
nich Wistar rat has made possible an assessment of
the functional effects of a variety of hormones, in-
cluding angiotensin II (All), prostaglandin E1
(PGE1), and other vasodilators, as well as para-
thyroid hormone and vasopressin, on the mamma-
lian glomerular microcirculation [1—6]. Of these,
All has been studied most extensively [1, 2, 4]. In
addition to vasoconstrictor effects on the renal cir-
culation, this hormone also has been shown to bring
about a pronounced lowering of the glomerular cap-
illary ultrafiltration coefficient (K1) [1, 4].
Several lines of evidence indicate that the cal-
cium ion is an important cofactor required for the
action of All on the renal microcirculation. Blanc et
a! found that the binding of All to isolated rat
glomeruli is highly sensitive to external calcium
concentrations [7]. Because the contractile re-
sponse of various smooth muscle tissues to All is
known to be critically dependent upon trans-
membrane calcium ion transport [8], the renal arte-
riolar vasoconstriction induced by All may also be
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sensitive to changes in calcium ion transport as
well. Likewise, because glomerular mesangial cells
contain contractile myofilaments, the reduction of
Kf brought about by All may also be related to
changes in calcium concentration or distribution,
with mesangial contraction bringing about the fall in
Kf by reducing glomerular capillary surface area.
The present experiments were therefore undertaken
in Munich Wistar rats to evaluate the role of cal-
cium ions in the action of All on the renal cortical
microcirculation in vivo.
Methods
General
Micropuncture studies were performed on 19
adult male Munich Wistar rats; each rat weighed
205 to 320 g and was allowed free access to water
and a standard rat pellet diet. Immediately after
anesthesia was induced with mactin (100 mg/kg,
i.p.), the left femoral artery was catheterized, and ap-
proximately 70 1.d of arterial blood was collected for
the baseline value. This arterial catheter was used
for subsequent periodic blood sampling and estima-
tion of mean femoral arterial pressure (AP). AP
was monitored with an electronic transducer (model
P23Db, Statham Instruments Div., Gould Inc., Ox-
nard, California) connected to a direct writing re-
corder (model 7754A, Hewlett-Packard Co., Palo
Alto, California). Polyethylene catheters were also
inserted into the right and left jugular veins for in-
fusions of inulin and isoncotic rat plasma, and into
the left femoral vein for infusion of All and/or vera-
pamil or manganese (see below). Intravenous in-
fusions were begun of homologous rat plasma (ob-
tained at time of micropuncture study by ex-
sanguination of a littermate) and 7.5% inulin
solution in 0.9% sodium chloride; the latter was
continued throughout the duration of each experi-
ment at a rate of 1.2 ml/hr. Following tracheostomy,
rats were prepared for micropuncture study as de-
scribed previously [9]. Throughout the period of
surgical preparation and experimental study, each
animal received a continuous infusion of isoncotic
rat plasma to maintain circulating plasma volume at
conscious (or euvolemic) levels. The following pro-
tocol [10] was used to prevent net loss of plasma
volume during preparation for micropuncture: Soon
after collection of the baseline left femoral arterial
blood sample (see above), isoncotic rat plasma was
infused for 45 mm at the rate of 7 to 10 mllkg/hr,
followed by reduction in infusion rate to 1.5 ml/kg/
hr for the remainder of each experiment. In addi-
tion, fine adjustments in plasma infusion rate were
made, based on the value for hematocrit of arterial
blood samples obtained at subsequent periodic in-
tervals.
In all experiments, micropuncture measurements
were carried out as follows: Exactly timed (1 to 2
mm) samples of tubule fluid were collected from
surface proximal convolutions of two or three neph-
rons for determination of flow rate and inulin con-
centration. These measurements permit calcula-
tion of single nephron glomerular filtration rate
(SNGFR). Coincident with these tubule fluid collec-
tions, two or three samples of femoral arterial blood
were obtained in each period for determination of
hematocrit and plasma concentrations of protein
and inulin. Whole blood, obtained on the morning
of study from a littermate, was injected after each
blood collection to replace (volume for volume)
blood withdrawn for analytical purposes. In addi-
tion, two or three samples of urine from the experi-
mental kidney were collected for determination of
flow rate, inulin concentration, and calculation of
total kidney glomerular filtration rate (GFR). For
these urine collections, indwelling ureteral polyeth-
ylene catheters (PE-lO) were used. Time-averaged
pressures were measured in surface glomerular cap-
illaries (PGC), proximal tubules (PT), and third-order
peritubular capillaries (Pr) with a continuous re-
cording, servo-null micropipette transducer system
(model 3, Instrumentation for Physiology and Medi-
cine, San Diego, California). Micropipettes with
outer tip diameters of 2 to 3 m and containing 2.0
M sodium chloride were used. Hydraulic output
from the servo system was coupled electronically to
a second channel of the Hewlett-Packard recorder
by means of a pressure transducer.
Colloid osmotic pressure (H) of plasma entering
and leaving glomerular capillaries was estimated
from values for protein concentrations (C) in femo-
ral arterial (CA) and surface efferent arteriolar (CE)
blood plasma samples, by using the equation de-
rived by Deen et al [9]. Values for CA, and thus 11A
for femoral arterial plasma are taken as representa-
tive of values of C and H for the afferent end of the
glomerular capillary network. These estimates of
preglomerular and postglomerular plasma protein
concentration permit calculation of single nephron
filtration fraction (SNFF) and ultrafiltration coeffi-
cient (Kf), as well as resistances of single afferent
(RA) and efferent (RE) arterioles, total resistance
(RTA), and initial glomerular capillary plasma flow
rate (QA), by using equations given below.
Group 1: All infusion followed by All + vera-
pamil infusion. We initially studied the effects of in-
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travenously administered All in a group of seven
rats to determine its actions on glomerular dynam-
ics in euvolemic rats. Three of the seven rats under-
went total thyroparathyroidectomy (TPTX) imme-
diately following tracheostomyt. Between 90 and
120 mm after onset of surgical preparation in all sev-
en rats, collections of tubule fluid, urine, efferent
arteriolar and femoral arterial blood, and measure-
ments of AP, PGC, and PT were begun and com-
pleted in the subsequent 45-mm interval. At the end
of this first study period, All amide (All; Hyper-
tensin®, Ciba) was infused intravenously at a rate
of 0.2 tgIkgImin; this All infusion was continued
throughout the duration of each experiment. Fol-
lowing a 15 to 60 mm equilibration period, measure-
ments of the various determinants of SNGFR were
repeated. Further, immediately following comple-
tion of this second study period, verapamil (Isoptin,
Knoll, Whippany, New Jersey) was given as a con-
tinuous i.v. infusion at the rate of 20 tgIkg/min. Fol-
lowing a 45-mm equilibration period from the start
of verapamil infusion, and while All infusion was
continued, all of the above described measurements
and collections were again repeated in the sub-
sequent 45 mm (third study period).
Group 2: Verapamil infusion followed by vera-
pamil + All infusion. In a separate group of seven
rats, we studied the effects of verapamil alone, and
of verapamil pretreatment of rats given All, on gb-
merular dynamics. In these euvolemic rats, the first
study period was carried out in identical fashion to
that used in group 1. Subsequently, verapamil was
given intravenously at the rate of 20 pg!kg/min, that
is, identical to the dose used in the third study peri-
od of group 2. Following a 45-mm equilibration peri-
od, measurements and collections of the quantities
specified above were repeated in the subsequent 45-
mm interval. Following this second study period,
infusion of All was begun at the rate of 0.2 g/kg/
mm, and the verapamil infusion was also continued.
Following a 30-mm equilibration period, pertinent
measurements and collections were again started
and completed in the subsequent 45-mm interval
(third study period).
Group 3: All infusion followed by All + manga-
nese infusion. The effects of manganese on All-in-
duced changes in gbomerular dynamics were exam-
ined in a third group of five euvolemic rats. In these
Because the plasma level of PTH has been found to influence
Kf [6], TP'FX was performed in the present study to ascertain
whether the results obtained with verapamil are dependent upon
the presence of PTH.
rats, following completion of surgical preparation
for micropuncture, the left adrenal artery that origi-
nated directly from the left renal artery was cathe-
terized in orthograde fashion with finely drawn PE-
10 tubing. Infusion of 0.9% sodium chloride was
then started at the rate of 0.6 mllhr. The first study
period was carried out exactly as in group 1. At the
end of initial measurements and collections, an All
infusion at the rate of 0.03 sg/kg/min (0.6 mllhr) was
substituted for the sodium chloride solution and
was continued for the duration of each experiment.
Following a 15- to 60-mm equilibration period, mea-
surements and collections were repeated in the sub-
sequent 45-mm interval. Immediately following
completion of this second study period, manganese
chloride also was given at a rate of 6.6 x b0 M/kg!
mm via the left renal artery. After 30 mm, repeat
collections and measurements were begun and com-
pleted in the next 45 mm.
Analytical
The volume of fluid collected from individual
proximal tubules was estimated from the length of
the fluid column in a constant bore capillary tube of
known internal diameter. The concentration of in-
ulin in tubule fluid was measured, usually in dupli-
cate, by the microfluorescence method of Vurek
and Pegram [11]. Inulin concentrations in plasma
and urine were determined by the macroanthrone
method of FUhr et al [12]. Protein concentrations in
efferent arteriolar and femoral arterial blood
plasmas were determined, usually in duplicate, us-
ing a fluorometric method recently developed by
Viets et al [13]. Phosphate concentrations in urine
and plasma were determined by a modification of
the method of Fiske and Subbarow [14].
Calculations
Single nephron glomerular filtration rate was
calculated as
SNGFR = (TFIP)1 VTF (1)
where (TF/P)1 and VTF refer to the tubule fluid to
plasma inulin concentration ratio and tubule fluid
flow rate, respectively.
Single nephron filtration fraction was calculated
as
SNFF 1 — (2)
where CA and CE denote afferent and efferent arteri-
olar protein concentrations, respectively.
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Initial glomerular capillary plasma flow rate was
calculated as
SNGFRQA = SNFF
Blood flow rate per single afferent arteriole or gb-
merulus was calculated as
GBF= QA1 — HctA
where HctA, the hematocrit of afferent arteriolar
blood, is taken as equal to femoral arterial hemato-
crit.
Efferent arteriolar blood flow rate was calculated
as
EABF = GBF - SNGFR
Resistance per single afferent arteriole was
— PGC
RA = GBF x (7.962 x l0'°)
where the factor 7.962 x 1O° is used to give resis-
tance in units of dynesseccm5 when AP and PGC
are expressed in mm Hg and GBF in nanoliters per
minute.
Resistance per single efferent arteriole was calcu-
lated as
D — PGC C oiz', irno
—
EABF "
Total arteriolar resistance for a single preglomer-
ular to postgomerular vascular unit was calculated
as
RTA = RA + RE
Mean glomerular transcapillary hydraulic pres-
sure difference was calculated as
=
— PT
The ultrafiltration coefficient (Kf) was calculated
with a differential equation that gives the rate of
change of protein concentration with distance along
an idealized glomerular capillary. This equation, to-
gether with its derivation and the method for its so-
lution, has been given in detail elsewhere [9].
Statistical analyses were performed by the paired
and unpaired t test, where appropriate. Statistical
significance is defined as P < 0.05.
Results
Results are shown in Table 1.
Measurements made during initial study (control)
period in groups 1 to 3. Initial measurements in
each of the three experimental groups were ob-
tained under identical euvolemic conditions. Be-
(3) cause the results obtained in three TPTX rats and
four non-TPTX rats in group 1 were essentially in-
distinguishable for all quantities measured, the val-
ues from these seven rats were pooled in all calcu-
lations. Values for total kidney GFR averaged 1.33
(4) (sEM) 0.09 in group I and 1.20 0.12 mllmin in
group 2. Although total kidney GFR was not mea-
sured in group 3, values for SNGFR were similar in
groups ito 3, averaging 40.3 1.4, 46.5 3.6, and
44.4 3.3 nL'min, respectively. Likewise, values
for QA were similar among groups, averaging 126
4 (group 1), 142 13 (group 2), and 131 8 nllmin
(5) (group 3). SNFF was therefore similar among thethree groups, averaging 0.32 0.01, 0.33 0.01,
and 0.34 0.01, respectively. Mean values for AP
and GC were Ill Sand 49.1 0.9 (group 1), 116
(6) 4 and 49.3 0.6 (group 2), and 118 4 mm Hg
and 48.4 0.5 mm Hg (group 3). Values for PT aver-
aged 14.3 0.6, 14.1 0.6, and 13.0± 0.6, respec-
tively. Therefore, mean values for zP were similar,
averaging 34.9 1.0, 35.1 1.0, and 35.4± 0.4mm
Hg, respectively, for groups ito 3. Mean values for
Pc were also similar (8.4 0.5, 7.6 0.8, and 8.0
0.3 mm Hg, respectively), as were values for CA
(5.8 0.1, 5.7 0.1, and 5.7 0.0 gIdl). Values for
(7) CE averaged 8.5 0.1 (group 1), 8.5 0.2 (group 2),
and 8.7 0.1 g/dl (group 3), not significantly dif-
ferent from group to group. 11E averaged 34.8 0.8,
35.2 1.1, and 36.2 0.9 mm Hg, respectively. In
each group, the average value for HE was not signif-
(8) icantly different from iP, as evidenced by ratios ofHE/P of 1.00 0.03 (group 1), 1.00 0.02 (group
2), and 1.02± 0.02 (group 3). This equality between
11E and zP, indicating achievement of filtration
(9) pressure equilibrium, obtained in most rats from
each group. Given filtration pressure equilibrium,
only minimu,n values for Kf could be calculated be-
cause of the uncertainty in determining exact zfl
profiles at equilibrium, for reasons given in detail
elsewhere [9]. Thus, minimum values for Kf calcu-
lated for the control study period in groups 1 to 3
averaged 0.091 0.009 (0.089 0.019 for TPTX
and 0.092 0.012 for non-TPTX rats), 0.098
0.009, and 0.096 0.009 nI/(sec.mm Hg), respec-
tively. Values for RA, RE, and RTA averaged 2.1
0.2, 1.7 0.1, and 3.8 0.2 x 1010 dynesseccm5
in group 1, 2.2 0.3, 1.7 0.2, and 3.8 0.5 in
group 2, and 2.2 0.2, 1.6 0.1, and 3.8 0.2 in
group 3, respectively. Overall, these values, ob-
tained under euvolemic conditions, are similar to
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those found by us recently under identical condi-
tions [10].
Group 1: Effects of All infusion, followed by All
+ verapamil infusion. Infusion of All resulted in a
uniform increase in AP, from 111 5 to 128 7 mm
Hg (P < 0.001). Whole kidney GFR declined slight-
ly, but significantly, during All infusion, from an
initial mean value of 1.33 0.09 to 1.14 0.05 mu
mm (P < 0.05). As shown in Fig. 1, SNGFR also fell
slightly (on average from 40.3 1.4 to 37.3 2.2 nIl
mm), but not significantly, during All infusion. Be-
cause QA declined to a greater extent (on average,
from 126 4 to 98 5 nllmin, P < 0.005), SNFF
rose significantly during infusion of All, on average
from 0.32 0.01 to 0.38 0.01 (P < 0.001).
rose significantly with All infusion, from 49.1 0.9
to 59.9 1.5 mm Hg (P < 0.001), whereas PT re-
mained essentially unchanged from initial values.
As a result, as shown in Fig. 1, P increased from
an initial mean value of 34.9 1.0 to 44.9 1.0mm
Hg with All (P < 0.001). Mean values for P re-
mained essentially unchanged with All infusion
(7.6 0.7 mm Hg during All). CA, and thus
"A, decreased slightly, but not significantly (from
5.8 0.1 to 5.5 0.1 g/dl), whereas values for
CE, and thus "E, showed a significant rise during
All infusion (from 34.8 0.8 to 37.8 1.3 mm Hg,
P < 0.05). Despite this increase in 11E the con-
comitant increase in zP was proportionately great-
er, so that filtration pressure equilibrium was abol-
ished during All infusion, as indicated by ratios of
llEItP averaging significantly less than unity (0.84
0.03, P < 0.001). Unique values for K1 could
therefore be calculated during All and were found
to be uniformly lower than were minimum values
for K1 measured prior to All in each rat (0.040
0.005 [0.043 0.006 for TPTX and 0.038 0.007 for
non-TPTX rats] vs.  0.091 0.009 nl/[sec.mm
Hg], P < 0.001), as shown in Fig. 1.
Calculated values for RA and RE are also given in
Fig. 1. As shown, RA and RE, and thus RTA, in-
creased significantly during All infusion, on aver-
age by approximately 40%, 75%, and 55%, respec-
tively (P < 0.005, P < 0.005, and P < 0.001). Over-
all, despite significant All-induced falls in both QA
and Kf, SNGFR fell only slightly, due to the oppos-
ing effect of the marked All-induced increase in zP,
the latter reflecting a proportionately greater in-
crease in RE than RA. Qualitatively similar findings
have been reported by us and others previously, in
studies using a similar dose of All in hydropenic as
well as plasma volume-expanded Munich Wistar
rats [1,2,4].
Despite continued infusion of All, the addition of
verapamil in the third study period served to de-
crease AP to levels (106 5 mm Hg, P < 0.001)
similar to those which existed prior to All infusion.
Values for whole kidney and single nephron GFR
increased slightly, but significantly, with verapamil
infusion, on average to 1.37 0.10 mllmin (P <
0.05) and 41.8 3.2 nL/min (P < 0.025), respective-
ly, both essentially equal to pre-All levels (Fig. 1).
Likewise, as shown in Fig. 1, QA increased signifi-
cantly, to 118 11 nI/mm (P < 0.025), a value also
essentially identical to the mean value measured
prior to All. Values for GC and P decreased to
values measured prior to All (PGc, to 49.4 1.4mm
Hg, P < 0.001; and to 34.7 1.4mm Hg, P <
0.001). Mean values for Pc remained essentially
unchanged (8.4 0.7 mm Hg), as did CA (5.5
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Fig. 1. Summary of changes in single nephron function in re-
sponse to i.v. infusion of All and All + verapamil in euvolemic
rats (N = 7). In this and subsequent figures, open circles denote
mean minimum Kf values calculated under conditions of filtra-
tion pressure equilibrium, and closed circles denote mean unique
Kf values calculated under conditions of filtration pressure dis-
equilibrium. All values shown in Figs. 1 to 3 are expressed as
means SEM. Abbreviations are defined as: SNGFR, single
nephron glomerular filtration rate; QA, initial glomerular capil-
lary plasma flow rate; P, mean glomerular transcapillary hy-
draulic pressure difference; K, ultrafiltration coefficient; RA and
R5, resistance to afferent and efferent arteriolar blood flow.
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Fig. 2. Summary of changes in single nephron function in re-
sponse to i.v. infusion of verapamil alone and verapamil + All in
euvolemic rats (N = 7). Abbreviations and symbols are defined
in Fig. 1.
0.1 gIdl) and hence 'IA. The ratio of IIE/P
averaged 1.02 0.02, indicating restoration of
filtration pressure equilibrium, as existed prior to
All infusion. Thus, verapamil infusion led to mini-
mum K1 values which were uniformly higher than
were unique values measured during All infusion
alone (P < 0.001), averaging 0.091 0.011 nIl
(secmm Hg) (0.092 0.019 for TPTX and 0.091
0.017 for non-TPTX rats), essentially identical to
values measured prior to All (Fig. 1).
As also summarized in Fig. 1, mean values for RA
and RE (and although not shown, RTA as well) de-
creased significantly with verapamil infusion de-
spite continued All infusion (P < 0.005, P < 0.001,
and P < 0.001, respectively), essentially to values
observed prior to All infusion. Thus, despite con-
tinued infusion of All, verapamil infusion resulted
in return of PGC, QA, K1, RA, RE (and RTA) essen-
tially to pre-All levels.
Group 2: Effects of verapamil infusion followed
by infusion of verapamil + All. Verapamil infusion
led to a uniform fall in AP, on average by 9 mm Hg
(from 116 4 to 107 5 mm Hg, P < 0.005). Whole
kidney and single nephron GFR both increased
slightly with verapamil infusion (on average, from
1.20 0.12 to 1.33 0.10 mllmin and from 46.5
3.6 to 52.3 4.0 nllmin, P < 0.05 for both). Like-
wise, as shown in Fig. 2, QA tended to increase very
slightly (from 142 13 to 152 13 nllmin), but the
change was not statistically significant. Accord-
ingly, SNFF remained essentially unchanged, aver-
aging 0.33 0.01 before and 0.34 0.01 during ye-
rapamil infusion. P and PT remained unaffected
by verapamil infusion. Thus, as shown in Fig. 2, the
mean value for zP was also unchanged, in contrast
to the significant and marked decreases observed in
AII-pretreated group-i rats given verapamil.
Values for P were largely unaffected by vera-
pamil infusion (7.6 0.8 before and 9.0 0.8
mm Hg during verapamil). As with CA (and hence
11A), values for CE (and thus HE) remained es-
sentially unchanged. The ratio of IIE/P there-
fore remained essentially equal to unity (from
1.00 0.02 to 1.02 0.01). Minimum values for K1
calculated during verapamil infusion were slightly,
but not significantly, higher than they were prior to
verapamil infusion, averaging 0.114 0.009 vs.
0.098 0.009 nll(sec mm Hg) (Fig. 2). As shown in
Fig. 2, verapamil infusion led to slight decreases in
RA and RE (and RTA), but the changes were statisti-
cally significant only for RA and RTA (P < 0.025 for
both). This tendency for these resistances to fall
with verapamil infusion suggests an action on en-
dogenous vasoconstrictor forces, including perhaps
All.
In these seven verapamil-treated rats, All was
given in the third period in a dose identical to that
used in group-i rats. As with whole kidney GFR
(1.26 0.06 ml/min), SNGFR remained essentially
unchanged (50.4 3.3 nllmin), as shown in Fig. 2.
Likewise, the mean value for QA was unaffected
(149 13 nllmin) (Fig. 2), in contrast to the signifi-
cant fall seen in group-i rats given All alone. SNFF
therefore remained unchanged during verapamil+
All. In contrast to the large increases in PGC and P
observed in group-i rats given All infusion alone,
PGC and PT remained largely unaffected by All in
the presence of verapamil; thus, the mean value for
P was also unchanged (Fig. 2). With All in-
fusion, P decreased slightly but not significant-
ly in group 2 (Table 1), whereas values for CA
(and hence HA) and C (hence HE) did not change
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appreciably. Accordingly, the ratio of HE/LW, on av-
erage, again remained at a value essentially equal to
unity (that is, 1.03 0.02), denoting persistence of
filtration pressure equilibrium. Mean minimum val-
ues for Kf during verapamil + All did not differ sig-
nificantly from values found during verapamil alone
(Fig. 2). Thus, the persistence of filtration equilibri-
um and the high K1 value are in marked contrast to
the filtration disequilibrium and the large reduction
in K1 seen in group-i rats given All alone. Also, in
contrast to marked increases in RA, RE, and RTA in-
duced by All in group-i rats, verapamil + All in-
fusion failed to affect these indices in group-2 rats to
any important extent (Fig. 2).
Group 3: Effects of All infusion followed by All
+ manganese infusion. As shown in Fig. 3, the
pattern of changes induced by All infusion and by
All + manganese infusion were essentially identical
to that seen in group 1. Thus, All failed to change
SNGFR appreciably, but led to a significant reduc-
tion in QA (Fig. 3). Accordingly, SNFF rose signifi-
cantly during All infusion, on average from 0.34
0.01 to 0.40 0.00.
As with systemic intravenous infusion of mildly
pressor dose of All, the nonpressor dose (AP aver-
aged 118 4 before and 116 4 mm Hg during All
infusion) of All infused via the left renal artery in
group 3 rats led to a marked rise in P0c, on average
from 48.4 0.5 to 59.2 1.0 mm Hg (P <0.025),
whereas P1 was unaffected. As a result, LW in-
creased, on average, from 35.4 0.4 to 46.6 1.0
mm Hg (P < 0.001) (Fig. 3). All infusion resulted in
a significant increase in CE (hence HE), on average
from 8.7 0.1 to 9.4 0.2 g/dl and from 36.2 0.9
to 41 1.5 mm Hg (P < 0.025 for both), whereas
CA (hence HA) remained unchanged. As in group-i
rats, since this increase in 11E was proportionately
smaller than was the concomitant increase in P,
filtration pressure equilibrium was abolished during
All infusion, as indicated by the ratio of HEIP av-
eraging significantly less than unity (0.89 0.03, P
<0.005). As shown in Fig. 3, unique values for K1
calculated during All infusion were lower than were
minimum values for K1 measured prior to All in-
fusion in each rat, averaging 0.044 0.006 vs. 0.096
0.010 nhl(sec.mm Hg) (P < 0.005). With intrarenal
arterial All infusion, whereas RE increased marked-
ly (Fig. 3), RA was found not to change appreciably.
Qualitatively, this is in contrast to results in group-i
rats, in which significant increases in RA were ob-
served with intravenous infusion of a pressor dose
of All (Fig. 1).
Whereas again AP remained essentially constant
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(on average, 116 4 before and 117 4 mm Hg
during manganese infusion), manganese infusion in
rats receiving intrarenal All served to reverse es-
sentially completely the changes induced by All in-
fusion alone, as shown in Fig. 3. With manganese
infusion, QA tended to increase to or toward pre-All
levels (Fig. 3). Despite continued infusion of All,
addition of manganese led to a marked decline in
PGC, on average from 59.2 1.0 to 50.6 0.7 mm
Hg, the latter similar to that measured prior to All
infusion. PT remained relatively unchanged so that
LW also decreased markedly, on average by 9 mm
Hg, as shown in Fig. 3. CA, and thus HA, also re-
mained unchanged. Values for CE (and thus HE) de-
creased slightly with manganese infusion, but not
significantly. Nevertheless, the ratio of HE/LW in-
creased and averaged 1.03 0.03 indicating that
manganese infusion restored filtration pressure
equilibrium. As shown in Fig. 3, minimum values for
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Fig. 3. Summary of changes in single nephron function in re-
sponse to intrarenal arterial infusion of All and All + manga-
nese in euvolemic rats (N = 5). Abbreviations and symbols are
defined in Fig. 1.
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K1 during All + manganese infusion were uniformly
higher than were unique values obtained during All
alone, averaging 0.088 0.006 vs. 0.044 0.006 nIl
(secmm Hg), the former essentially indistinguish-
able from values obtained prior to All infusion
(0.096 0.010 nl/[secmm Hg]). As also shown in
Fig. 3, values for RA, which were unaffected by All
alone, remained essentially unchanged during All
+ manganese infusion. RE, however, decreased
significantly with manganese infusion, on average
by approximately 30%.
Discussion
In the present studies, intravenous infusion of a
mildly pressor dose of All resulted in marked in-
creases in PGC, and thus P, in euvolemic rats. All
infusion also led to a significant reduction in QA, but
not in SNGFR, so that SNFF increased. The rela-
tive constancy of SNGFR in the presence of a large
increase in P necessitates the conclusion that the
glomerular capillary ultrafiltration coefficient, K1,
declined with All. Also, it was found that the reduc-
tion in QA and the concomitant rise in PGC were con-
sequences of the preferential vasoconstrictor action
of All on efferent arterioles. Overall, these re-
sponses of the renal cortical microcirculation to All
infusion are in close agreement with those reported
by us previously [2, 4], as well as by Blantz, Kon-
nen, and Tucker [1].
There is reason to believe that the calcium ion is
an important modulator for the expression of these
various actions of All on the renal cortical micro-
circulation. In a recent series of experiments, Blanc
et al [7] demonstrated that specific binding of All to
isolated rat glomeruli is highly sensitive to external
calcium concentrations. Also, the contractile re-
sponse of smooth muscle to All has been shown to
be critically dependent upon transmembrane cal-
cium ion transport. Thus, in a recent in vitro study,
Freer [8] demonstrated that following incubation of
rat uterine smooth muscle either in a zero calcium
medium or in the presence of verapamil, a known
antagonist of transcellular calcium ion transport
[15—18], the contractile response of this tissue to
All was essentially abolished.
The effects of verapamil in modifying the in vivo
action of All on the glomerular microcirculation
were therefore examined in the present study.
Whereas verapamil infusion alone failed to alter PGC
or P significantly, an identical dose of verapamil
given during All administration resulted in marked
reductions in P and zP, essentially to pre-AIl lev-
els (Fig. 1). Verapamil infusion in All-treated rats
also served to reverse the declines in QA and Kf
noted in response to All alone. The rise in QA to
pre-All levels with verapamil was found to be the
consequence of return of afferent and efferent arte-
riolar resistances to levels which existed prior to
All infusion. By contrast, the effects of verapamil
on these resistances in rats not pretreated with All
were relatively small, suggesting that the reversal of
the All-induced effects were not due simply to a
vasodilatory action of verapamil, but rather to a
specific reversal of All action. This conclusion is
further supported by the data from group-2 rats
(Fig. 2) in that pretreatment of these rats with ye-
rapamil virtually prevented the vasoconstrictor and
K1-lowering effects of All on the glomerular micro-
circulation.
To ascertain whether these inhibitory influences
of verapamil on the various renal actions of exoge-
nous All are due to its effects on calcium ion trans-
port itself, we used manganese, another known
antagonist of calcium entry into cells [18—2 1] in All-
pretreated rats (group 3).
As with verapamil, manganese infusion also re-
versed the All-induced effects on PGC, QA, RE, and
K1. In these rats, manganese was given by intra-
renal arterial infusion to achieve high local concen-
trations and minimal systemic action. All was also
infused via the renal artery, allowing us to define
the effects of a high local, but systemically non-
pressor, dose of All on the renal cortical micro-
circulation. This route of administration of All and
manganese thus enabled us to ascertain whether the
changes in GC, QA, RA, RE, and K1 observed in as-
sociation with a rise in AP in group-i rats were a
consequence of All itself, rather than due to some
secondary renal microvascular response to the rise
in AP. Thus, infusion of 1.8 glkg/hr of All, one
tenth the dose used systemically, proved to be non-
pressor when given via the renal artery. When given
via this route, All failed to lead to a rise in RA,
whereas all of the other effects noted with pressor
doses of All were duplicated. This finding, that the
rise in RA is abolished when renal arterial perfusion
pressure is prevented from rising, is in close accord
with previous observations from this laboratory [2],
and suggests that the efferent arteriole is the prima-
ry renal locus of vasoconstriction in response to
All.
Collectively, reversal of the exogenous All-in-
duced changes in the renal cortical microcirculation
by verapamil and manganese infusion, two chem-
ically distinct antagonists of transcellular calcium
ion transport, provides evidence that calcium may
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be an important cofactor required for expression of
the intrarenal actions of All. Since glomerular
mesangium contains an abundance of contractile
myofilaments, it is possible that the Kf-lowering
effect of All is mediated by mesangial contraction,
which thereby serves to reduce the glomerular cap-
illary surface area available for ultrafiltration. In
keeping with this possibility, Osborne et al [22], us-
ing autoradiography in rats, observed localization
of radiolabeled All in glomeruli, and predominantly
in mesangial areas. Also, using scanning electron
microscopy, Hornych, Beaufils, and Richet [23]
demonstrated contraction of the glomerular capil-
lary network in rats treated with All in doses simi-
lar to those used in the present study. Verapamil
and manganese may therefore inhibit the mesangial
contractile response to exogenous All by blocking
entry of calcium into smooth muscle cells and thus
interfering with excitation-contraction coupling, and
hence prevent or abolish the Kr-lowering effect of
All. Likewise, calcium appears to play a key
role in All-induced contraction of the efferent arte-
riole, accounting for the observed antagonistic ef-
fects of verapamil and manganese on All-induced
changes in PGC, QA, and RE.
Of interest are the recent findings from our labo-
ratory that, in addition to All, other hormones, in-
cluding vasopressin [5], PTH [6], prostaglandin E1
[3], acetylcholine [3], as well as histamine [24] also
serve to reduce Kf. Moreover, verapamil also re-
verses the fall in K induced by two of these hor-
mones administered exogenously, namely, prosta-
glandin E1 and acetylcholine (Ichikawa and Bren-
ner, unpublished observations). The present findings
therefore suggest that calcium plays an important
role in the action of several hormones in lowering
glomerular Kf, perhaps by the general mechanism
of triggering mesangial contraction. As in other
smooth muscle systems, this contractile process ap-
pears to be abolished by verapamil or manganese.
Obviously, future studies are required to evaluate
whether the inhibitory effects of calcium-entry an-
tagonists on the renal actions of exogenously ad-
ministered All are also demonstrable for endoge-
nous All, when the latter is varied by appropriate
physiologic manipulations (that is, salt depletion).
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